Literature DB >> 29436341

Retrospective Analysis of Fever and Sepsis Patients from Cambodia Reveals Serological Evidence of Melioidosis.

Vichaya Suttisunhakul1, Phireak Hip2, Pidor Ouch2, Piseth Ly2, Chonthida Supaprom2, Agus Rachmat2, Michael Prouty2, Andrew Vaughn2, Ahreej Eltayeb3,4, Sim Kheng5, Danielle V Clark3,4, James V Lawler3,4, Narisara Chantratita6,1, Mary N Burtnick7, Paul J Brett7, Kevin L Schully3,4.   

Abstract

Burkholderia pseudomallei, the etiologic agent of melioidosis, is predicted to be ubiquitous in tropical regions of the world with areas of highest endemicity throughout Southeast Asia (SEA). Nevertheless, the distribution of B. pseudomallei and the burden of melioidosis in many SEA countries remain unclear. In Cambodia, only two human endemic cases of melioidosis were reported through 2008 and since then only a few hundred cases have been described in the literature. This is in sharp contrast to the annual burden of thousands of cases in surrounding areas. To further investigate the prevalence of melioidosis in Cambodia, we used a recently developed O-polysaccharide-based rapid enzyme-linked immunosorbent assay to detect B. pseudomallei-specific antibodies in serum samples obtained from 1,316 febrile illness or sepsis patients from 10 different provinces. Based on a cutoff value derived through culture-confirmed melioidosis cases, the proportion of positive samples in our cohort was approximately 12%. Regression analysis indicated that the odds of obtaining a positive result were 2.2 times higher for males than females controlling for age and province (95% confidence interval: 1.6-3.2, P < 0.001). Consistent with this, 9.2% of females were positive versus 18.2% of males (P < 0.001). Notably, 22.5% of grain or rice farmers were positive versus 10.1% of subjects with occupations not involving regular contact with soil. Positive results varied significantly by province. Collectively, the results of this study suggest that the true burden of melioidosis in Cambodia is greater than has previously been reported.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29436341      PMCID: PMC5928837          DOI: 10.4269/ajtmh.17-0885

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1992. A 43-year-old Cambodian man with several years of recurrent bouts of fever and abdominal pain.

Authors: 
Journal:  N Engl J Med       Date:  1992-10-08       Impact factor: 91.245

Review 2.  Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment.

Authors:  Bart J Currie
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

3.  Emergence of pediatric melioidosis in Siem Reap, Cambodia.

Authors:  Yos Pagnarith; Varun Kumar; Janjira Thaipadungpanit; Vanaporn Wuthiekanun; Premjit Amornchai; Lina Sin; Nicholas P Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

4.  Indirect hemagglutination assay in patients with melioidosis in northern Australia.

Authors:  Allen C Cheng; Mathew O'brien; Kevin Freeman; Gary Lum; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

5.  Melioidosis, phnom penh, Cambodia.

Authors:  Erika Vlieghe; Lim Kruy; Birgit De Smet; Chun Kham; Chhun Heng Veng; Thong Phe; Olivier Koole; Sopheak Thai; Lut Lynen; Jan Jacobs
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

6.  Burkholderia pseudomallei traced to water treatment plant in Australia.

Authors:  T J Inglis; S C Garrow; M Henderson; A Clair; J Sampson; L O'Reilly; B Cameron
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

7.  A retrospective analysis of melioidosis in Cambodian children, 2009-2013.

Authors:  Paul Turner; Sabine Kloprogge; Thyl Miliya; Sona Soeng; Pisey Tan; Poda Sar; Pagnarith Yos; Catrin E Moore; Vanaporn Wuthiekanun; Direk Limmathurotsakul; Claudia Turner; Nicholas P J Day; David A B Dance
Journal:  BMC Infect Dis       Date:  2016-11-21       Impact factor: 3.090

8.  A prospective study of the causes of febrile illness requiring hospitalization in children in Cambodia.

Authors:  Kheng Chheng; Michael J Carter; Kate Emary; Ngoun Chanpheaktra; Catrin E Moore; Nicole Stoesser; Hor Putchhat; Soeng Sona; Sin Reaksmey; Paul Kitsutani; Borann Sar; H Rogier van Doorn; Nguyen Hanh Uyen; Le Van Tan; Daniel H Paris; Daniel Paris; Stuart D Blacksell; Premjit Amornchai; Vanaporn Wuthiekanun; Christopher M Parry; Nicholas P J Day; Varun Kumar
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  Burkholderia pseudomallei antibodies in children, Cambodia.

Authors:  Vanaporn Wuthiekanun; Ngoun Pheaktra; Hor Putchhat; Lina Sin; Bun Sen; Varun Kumar; Sayan Langla; Sharon J Peacock; Nicholas P Day
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Melioidosis in lower provincial Cambodia: A case series from a prospective study of sepsis in Takeo Province.

Authors:  Kevin L Schully; Catherine M Berjohn; Angela M Prouty; Amitha Fitkariwala; Tin Som; Darith Sieng; Michael J Gregory; Andrew Vaughn; Sim Kheng; Vantha Te; Christopher A Duplessis; James V Lawler; Danielle V Clark
Journal:  PLoS Negl Trop Dis       Date:  2017-09-13
View more
  3 in total

1.  Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients.

Authors:  Apinya Pumpuang; Rungnapa Phunpang; Peeraya Ekchariyawat; Adul Dulsuk; Siriorn Loupha; Kochnipa Kwawong; Yaowaree Charoensawat; Ekkachai Thiansukhon; Nicholas P J Day; Mary N Burtnick; Paul J Brett; T Eoin West; Narisara Chantratita
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

2.  Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.

Authors:  Sineenart Sengyee; Atchara Yarasai; Rachan Janon; Chumpol Morakot; Orawan Ottiwet; Lindsey K Schmidt; T Eoin West; Mary N Burtnick; Narisara Chantratita; Paul J Brett
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

3.  GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.

Authors:  Jeffry D Shearer; Michelle L Saylor; Christine M Butler; Anthony M Treston; Henry S Heine; Sunisa Chirakul; Herbert P Schweizer; Arnold Louie; George L Drusano; Steven D Zumbrun; Kelly L Warfield
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.